{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T12:48:57Z","timestamp":1781268537485,"version":"3.54.1"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To compare the risk of ventricular arrhythmias (VA) and sudden death (SD) between New York Heart Association (NYHA) class I and NYHA class II\u2013III patients with non-ischaemic cardiomyopathy (NICM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Observational retrospective cohort study including patients with NICM who underwent cardiac magnetic resonance at two hospitals. The primary endpoint included appropriate implantable cardioverter defibrillator (ICD) therapies, sustained ventricular tachycardia, resuscitated cardiac arrest and SD. The secondary endpoint included heart failure (HF) hospitalizations, heart transplant, left ventricular assist device implant or HF death. Overall, 698 patients were included, 33% in NYHA class I. During a median follow-up of 31\u2009months, the primary endpoint occurred in 57 patients (8%), with no differences between NYHA class I and NYHA class II\u2013III cases (7% vs. 9%, p = 0.62). Late gadolinium enhancement (LGE) was the only independent predictor of the primary outcome both in NYHA class I and NYHA class II\u2013III patients. LGE+ NYHA class I patients had a similar cumulative incidence of the primary endpoint as compared to LGE+ NYHA class II\u2013III (p = 0.92) and a significantly higher risk as compared to LGE\u2013 NYHA class II\u2013III cases (p\u2009&amp;lt;\u20090.001). The risk of the secondary endpoint was significantly higher in patients in NYHA class II\u2013III as compared to those in NYHA class I (hazard ratio 3.2, p = 0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with NICM in NYHA class I are not necessarily at low risk of VA and SD. Actually, LGE+ NYHA class I patients have a high risk. NYHA class I patients with high-risk factors, such as LGE, could benefit from primary prevention ICD at least as much as those in NYHA class II\u2013III with the same risk factors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.2793","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T20:26:20Z","timestamp":1676319980000},"page":"740-750","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Late Gadolinium Enhancement and the Risk of Ventricular Arrhythmias and Sudden Death in NYHA Class I Patients with Non-Ischaemic Cardiomyopathy"],"prefix":"10.1093","volume":"25","author":[{"given":"Andrea","family":"Di Marco","sequence":"first","affiliation":[{"name":"Department of Cardiology, Hospital Universitari de Bellvitge , Barcelona ,","place":["Spain"]},{"name":"Bioheart-Cardiovascular Diseases Group, Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Institut d'Investigaci\u00f3 Biom\u00e8dica de Bellvitge\u2013IDIBELL , Barcelona ,","place":["Spain"]},{"name":"Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre , Manchester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Cardiology, North West Heart Centre, Manchester University NHS Foundation Trust , Manchester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Mateus","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Universitari de Bellvitge , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Faga","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Universitari de Bellvitge , Barcelona ,","place":["Spain"]},{"name":"Bioheart-Cardiovascular Diseases Group, Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Institut d'Investigaci\u00f3 Biom\u00e8dica de Bellvitge\u2013IDIBELL , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Nucifora","sequence":"additional","affiliation":[{"name":"Department of Cardiology, North West Heart Centre, Manchester University NHS Foundation Trust , Manchester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Claver","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Universitari de Bellvitge , Barcelona ,","place":["Spain"]},{"name":"Bioheart-Cardiovascular Diseases Group, Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Institut d'Investigaci\u00f3 Biom\u00e8dica de Bellvitge\u2013IDIBELL , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisela","family":"Viedma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Universitari de Bellvitge , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Galvan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Universitari de Bellvitge , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Bradley","sequence":"additional","affiliation":[{"name":"Department of Cardiology, North West Heart Centre, Manchester University NHS Foundation Trust , Manchester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo D.","family":"Dallaglio","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Universitari de Bellvitge , Barcelona ,","place":["Spain"]},{"name":"Bioheart-Cardiovascular Diseases Group, Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Institut d'Investigaci\u00f3 Biom\u00e8dica de Bellvitge\u2013IDIBELL , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"de Frutos","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Universitari de Bellvitge , Barcelona ,","place":["Spain"]},{"name":"Bioheart-Cardiovascular Diseases Group, Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Institut d'Investigaci\u00f3 Biom\u00e8dica de Bellvitge\u2013IDIBELL , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Miller","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre , Manchester ,","place":["UK"]},{"name":"Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre , Manchester ,","place":["UK"]},{"name":"Wellcome Centre for Cell-Matrix Research, Division of Cell-Matrix Biology & Regenerative Medicine, School of Biology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre , Manchester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Com\u00edn-Colet","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Universitari de Bellvitge , Barcelona ,","place":["Spain"]},{"name":"Bioheart-Cardiovascular Diseases Group, Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Institut d'Investigaci\u00f3 Biom\u00e8dica de Bellvitge\u2013IDIBELL , Barcelona ,","place":["Spain"]},{"name":"Department of Clinical Sciences, School of Medicine, University of Barcelona , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignasi","family":"Anguera","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Universitari de Bellvitge , Barcelona ,","place":["Spain"]},{"name":"Bioheart-Cardiovascular Diseases Group, Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Institut d'Investigaci\u00f3 Biom\u00e8dica de Bellvitge\u2013IDIBELL , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schmitt","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre , Manchester ,","place":["UK"]},{"name":"Department of Cardiology, North West Heart Centre, Manchester University NHS Foundation Trust , Manchester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,2,22]]},"reference":[{"key":"2026010913090927300_ejhf2793-bib-0001","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"2026010913090927300_ejhf2793-bib-0002","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"K\u00f8ber","year":"2016","journal-title":"N Engl J Med"},{"key":"2026010913090927300_ejhf2793-bib-0003","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026010913090927300_ejhf2793-bib-0004","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","article-title":"2017 AHA\/ACC\/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026010913090927300_ejhf2793-bib-0005","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.010105","article-title":"Prognostic value of late gadolinium enhancement for the prediction of cardiovascular outcomes in dilated cardiomyopathy: an international, multi-institutional study of the MINICOR Group","volume":"13","author":"Alba","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026010913090927300_ejhf2793-bib-0006","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1161\/CIRCULATIONAHA.120.048477","article-title":"Relationship of LVEF and myocardial scar to long-term mortality risk and mode of death in patients with nonischemic cardiomyopathy","volume":"143","author":"Klem","year":"2021","journal-title":"Circulation"},{"key":"2026010913090927300_ejhf2793-bib-0007","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/europace\/euaa401","article-title":"CarDiac magnEtic Resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Ischaemic dilated CardioMyopathy: an international registry","volume":"23","author":"Guaricci","year":"2021","journal-title":"Europace"},{"key":"2026010913090927300_ejhf2793-bib-0008","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jchf.2016.09.017","article-title":"Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis","volume":"5","author":"Di Marco","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2026010913090927300_ejhf2793-bib-0009","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/jmri.23892","article-title":"Quantification of left ventricular indices from SSFP cine imaging: impact of real-world variability in analysis methodology and utility of geometric modeling","volume":"37","author":"Miller","year":"2013","journal-title":"J Magn Reson Imaging"},{"key":"2026010913090927300_ejhf2793-bib-0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1532-429X-15-35","article-title":"Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing","volume":"15","author":"Schulz-Menger","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026010913090927300_ejhf2793-bib-0011","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"2026010913090927300_ejhf2793-bib-0012","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/ehjci\/jeac109","article-title":"Prognostic impact of late gadolinium enhancement at the right ventricular insertion points in non-ischaemic dilated cardiomyopathy","volume":"24","author":"Claver","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026010913090927300_ejhf2793-bib-0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208100","article-title":"Prognostic implications of late gadolinium enhancement at the right ventricular insertion point in patients with non-ischemic dilated cardiomyopathy: a multicenter retrospective cohort study","volume":"13","author":"Yi","year":"2018","journal-title":"PLoS One"},{"key":"2026010913090927300_ejhf2793-bib-0014","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N Engl J Med"},{"key":"2026010913090927300_ejhf2793-bib-0015","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2013.4598","article-title":"Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial","volume":"309","author":"Gasparini","year":"2013","journal-title":"JAMA"},{"key":"2026010913090927300_ejhf2793-bib-0016","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE Trans Automat Contr"},{"key":"2026010913090927300_ejhf2793-bib-0017","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.jcmg.2018.07.015","article-title":"Outcome in dilated cardiomyopathy related to the extent, location, and pattern of late gadolinium enhancement","volume":"12","author":"Halliday","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026010913090927300_ejhf2793-bib-0018","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijcard.2020.02.025","article-title":"Risk of sudden cardiac death in New York Heart Association class I patients with dilated cardiomyopathy: a competing risk analysis","volume":"307","author":"Stolfo","year":"2020","journal-title":"Int J Cardiol"},{"key":"2026010913090927300_ejhf2793-bib-0019","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N Engl J Med"},{"key":"2026010913090927300_ejhf2793-bib-0020","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.amjcard.2017.11.032","article-title":"Long-term survival with implantable cardioverter-defibrillator in different symptomatic functional classes of heart failure","volume":"121","author":"Biton","year":"2018","journal-title":"Am J Cardiol"},{"key":"2026010913090927300_ejhf2793-bib-0021","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/j.jacc.2021.04.030","article-title":"Improved risk stratification for ventricular arrhythmias and sudden death in patients with nonischemic dilated cardiomyopathy","volume":"77","author":"Di Marco","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026010913090927300_ejhf2793-bib-0022","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J."},{"key":"2026010913090927300_ejhf2793-bib-0023","doi-asserted-by":"crossref","DOI":"10.1111\/anec.12420","article-title":"Cardiovascular magnetic resonance-GUIDEd management of mild to moderate left ventricular systolic dysfunction (CMR GUIDE): study protocol for a randomized controlled trial","volume":"22","author":"Selvanayagam","year":"2017","journal-title":"Ann Noninvasive Electrocardiol"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ejhf.2793","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ejhf.2793","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/25\/5\/740\/65494001\/eurjhf_25_5_740.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/25\/5\/740\/65494001\/eurjhf_25_5_740.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:11:07Z","timestamp":1767982267000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/25\/5\/740\/8341786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,22]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,2,22]]},"published-print":{"date-parts":[[2023,5,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.2793","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,5]]},"published":{"date-parts":[[2023,2,22]]},"assertion":[{"value":"2022-10-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}